Rchr
J-GLOBAL ID:201601007900946099
Update date: Jun. 05, 2020
Tomoko Mizuno
ミズノ トモコ | Tomoko Mizuno
Affiliation and department:
Gifu University University Hospital
About Gifu University University Hospital
Search "Gifu University University Hospital"
Detailed information
Research field (1):
Obstetrics and gynecology
Research keywords (2):
卵巣癌
, 低酸素
MISC (8):
Hiroshi Makino, Shin Nishio, Hiroshi Tsubamoto, Muneaki Shimada, Ryutaro Nishikawa, Kentaro Kai, Kimihiko Ito, Tomoko Mizuno, Kimio Ushijima, Ken-ichiro Morishige. Treatment and prognosis of bone metastasis from cervical cancer (KCOG-G1202s). JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 2016. 42. 6. 701-706
T. Mizuno, N. Suzuki, H. Makino, T. Furui, E. Morii, H. Aoki, T. Kunisada, M. Yano, S. Kuji, Y. Hirashima, et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. GYNECOLOGIC ONCOLOGY. 2015. 137. 2. 299-305
Yasuto Kinose, Kenjiro Sawada, Hiroshi Makino, Tomonori Ogura, Tomoko Mizuno, Noriko Suzuki, Tomoyuki Fujikawa, Eiichi Morii, Koji Nakamura, Ikuko Sawada, et al. IKK beta Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment. MOLECULAR CANCER THERAPEUTICS. 2015. 14. 4. 909-919
Aki Isobe, Kenjiro K Sawada, Yasuto Kinose, Chifumi Ohyagi-Hara, Erika Nakatsuka, Hiroshi Makino, Tomonori Ogura, Tomoko Mizuno, Noriko Suzuki, Eiichi Morii, et al. Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer. PLOS ONE. 2015. 10. 2
T. Mizuno, H. Takagi, K. Matsunami, A. Imai. Sequential methotrexate treatment with and estrogen and progestin in a retained adhesive placenta. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY. 2010. 37. 4. 331-332
more...
Work history (1):
2013 - Gifu University University Hospital
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM